Abstract | OBJECTIVE: To update a published meta-analysis of double-blind placebo-controlled randomized clinical trials (RCTs) to assess the efficacy of chondroitin sulfate as a structure-modifying drug for knee osteoarthritis (OA). DESIGN: A published meta-analysis of randomized controlled trials was updated to include data from one new trial and final data from a second trial both published recently in peer-reviewed literature. This meta-analysis was limited to three RCTs of 2-year duration. Data were pooled using a fixed effects model as there was no evidence of important heterogeneity. RESULTS: Pooled results demonstrated a small significant effect of chondroitin sulfate on the reduction in rate of decline in minimum joint space width of 0.13 mm [95% confidence interval (CI) 0.06, 0.19] (P=0.0002) that corresponded to an effect size of 0.23 (95% CI 0.11, 0.35) (P=0.0001). CONCLUSION: These results demonstrate that chondroitin sulfate is effective for reducing the rate of decline in minimum joint space width in patients with knee OA.
|
Authors | M C Hochberg |
Journal | Osteoarthritis and cartilage
(Osteoarthritis Cartilage)
Vol. 18 Suppl 1
Pg. S28-31
(Jun 2010)
ISSN: 1522-9653 [Electronic] England |
PMID | 20399895
(Publication Type: Journal Article, Meta-Analysis, Research Support, Non-U.S. Gov't, Review)
|
Copyright | Copyright 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved. |
Chemical References |
- Anti-Inflammatory Agents
- Chondroitin Sulfates
|
Topics |
- Anti-Inflammatory Agents
(therapeutic use)
- Chondroitin Sulfates
(therapeutic use)
- Double-Blind Method
- Female
- Humans
- Male
- Middle Aged
- Osteoarthritis, Knee
(drug therapy, pathology)
- Randomized Controlled Trials as Topic
|